Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Cardiovascular Business
cardiovascularbusiness.com > topics > clinical > cardiac-surgery > surgeon-hails-new-cabg-technology-technical-breakthrough

Surgeon hails new CABG technology as a 'technical breakthrough"

54+ min ago   (299+ words) Cardiovascular Business is an independent news site that reports on cardiovascular health and medicine for an audience of healthcare and medical professionals. Our team of journalists focus on strategies in economics, practice and technology. Every day, we dig into how…...

Cardiovascular Business
cardiovascularbusiness.com > topics > healthcare-management > legal-news > novo-nordisk-sues-glp-1-rival-eli-lilly-over-claims-false-advertising

Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertising

1+ day, 2+ hour ago   (341+ words) Cardiovascular Business is an independent news site that reports on cardiovascular health and medicine for an audience of healthcare and medical professionals. Our team of journalists focus on strategies in economics, practice and technology. Every day, we dig into how…...

Cardiovascular Business
cardiovascularbusiness.com > topics > clinical > heart-rhythm > steerable-sheaths-pfa-recalled-due-safety-risk

Steerable sheaths for PFA recalled due to safety risk

1+ day, 5+ hour ago   (168+ words) Boston Scientific has recalled more than 750,000 steerable sheaths used during pulsed field ablation (PFA) procedures. This recall only applies to specific lots of these steerable sheaths; no PFA catheters or other related devices are included. The U.S. Food and Drug Administration…...

Cardiovascular Business
cardiovascularbusiness.com > topics > clinical > pharmaceutics > wegovy-weight-loss-and-cardiovascular-health-closer-look-how-semaglutide-protects-heart

Wegovy, weight loss and cardiovascular health: A closer look at how semaglutide protects the heart

5+ day, 4+ hour ago   (375+ words) Cardiovascular Business is an independent news site that reports on cardiovascular health and medicine for an audience of healthcare and medical professionals. Our team of journalists focus on strategies in economics, practice and technology. Every day, we dig into how…...

Cardiovascular Business
cardiovascularbusiness.com > newsletter > 2026-07-15 > heart-valve-delivery-system-recalled-surgeon-makes-history-head-head-ttvr-study-now-underway-tavr

Heart valve delivery system recalled | Surgeon makes history | Head-to-head TTVR study now underway | TAVR & SAVR outcomes

1+ week, 3+ hour ago   (200+ words) The same device was previously recalled back in 2022. Customers are urged to return any unused delivery systems included in the recall to Medtronic. A surgeon in Michigan has performed the world’s first single-port robotic mitral valve repair. Major TAVR policy…...

Cardiovascular Business
cardiovascularbusiness.com > topics > clinical > acute-coronary-syndromes > heart-patients-more-likely-die-during-major-cardiology-conferences

Heart patients more likely to die during major cardiology conferences

1+ week, 1+ day ago   (432+ words) Cardiovascular Business is an independent news site that reports on cardiovascular health and medicine for an audience of healthcare and medical professionals. Our team of journalists focus on strategies in economics, practice and technology. Every day, we dig into how…...

Cardiovascular Business
cardiovascularbusiness.com > topics > clinical > interventional-cardiology > fda-clearance-triggers-115m-payment-conavi-medical

FDA clearance triggers $1.15M payment for Conavi Medical

3+ week, 1+ day ago   (260+ words) Cardiovascular Business is an independent news site that reports on cardiovascular health and medicine for an audience of healthcare and medical professionals. Our team of journalists focus on strategies in economics, practice and technology. Every day, we dig into how…...

Cardiovascular Business
cardiovascularbusiness.com > topics > clinical > heart-failure > heart-failure-drug-recalled-due-risk-contamination

Heart failure drug recalled due to risk of contamination

3+ week, 1+ day ago   (274+ words) Cardiovascular Business is an independent news site that reports on cardiovascular health and medicine for an audience of healthcare and medical professionals. Our team of journalists focus on strategies in economics, practice and technology. Every day, we dig into how…...

Cardiovascular Business
cardiovascularbusiness.com > topics > healthcare-management > healthcare-policy > trump-administration-warns-public-about-risk-fraudulent-testing-schemes

Trump administration warns public about risk of fraudulent testing schemes

3+ week, 2+ day ago   (147+ words) The U.S. government is warning the public about fraudulent cardiovascular testing scams that use "fear-based marketing" to put young people at risk. Healthcare facilities are exploiting fears about sudden cardiac arrest by pushing for unnecessary electrocardiograms and echocardiograms to be performed…...

Cardiovascular Business
cardiovascularbusiness.com > topics > clinical > structural-heart-disease > tavr > cms-proposes-major-tavr-changes-including-medicare-coverage-asymptomatic-patients

CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients

1+ mon, 6+ day ago   (540+ words) After months of consideration, the U.S. Centers for Medicare and Medicaid Services (CMS) has proposed substantial changes to current transcatheter aortic valve replacement (TAVR) coverage policies. One of those changes, if finalized, would require Medicare to cover TAVR for the treatment…...